ViiV Healthcare announces positive of Phase III Study of HIV-treatment regimen
ViiV has co-developed the injectable regimen in collaboration with Janssen Sciences and has submitted to regulatory authorities in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Aug 19
ViiV has co-developed the injectable regimen in collaboration with Janssen Sciences and has submitted to regulatory authorities in…
21 Aug 19
DAPA-HF marks the first trial on heart failure outcomes with an SGLT2 inhibitor in patients with and without…
05 Jun 19
The antidiabetic medication metformin reduces anxiety-like behaviours in male mice by increasing serotonin availability in the brain, according…
30 May 19
Using artificial intelligence (AI), researchers at the Technical University of Munich (TUM) have developed software to analyse the…
29 May 19
On 11 and 12 of September, Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals…
18 Feb 19
Researchers at the University of Louisville have been testing a protein-based molecule they originally developed to boost T…
16 Jan 19
On 1 January 2019, the new code of practice of the International Federation of Pharmaceutical Manufacturers and Associations…
01 Feb 15
A study by scientists from the University of Texas (UT) Medical Center suggests there is a strong link…
21 Jan 15
A potentially groundbreaking heart attack test could save women’s lives, according to recent research. A study funded by…
19 Mar 14
Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport® in the treatment of neurogenic…